ME/CFS Evidence Browser — Classified Studies on Myalgic Encephalomyelitis

901–920 of 6,157 studies

Levels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndrome.

Cleare, A J, O'Keane, V, Miell, J P·Psychoneuroendocrinology·2004

This study looked at stress hormone levels in people with ME/CFS, specifically a hormone called DHEA that affects mood, memory, and sleep. Researchers compared 16 ME/CFS patients to 16 healthy controls and tested how their bodies responded to a hormone challenge. They also gave some patients a low-dose steroid medication for a month to see if it helped. The findings suggest that DHEA levels are higher in ME/CFS and may relate to how disabled patients feel, and that low-dose steroid treatment can lower these levels and improve symptoms in some patients.

Evidence Atlas

Evidence browser

Levels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndrome.

Randomised controlled trial of graded exercise in chronic fatigue syndrome.

Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial.

L-carnitine decreases severity and type of fatigue induced by interferon-alpha in the treatment of patients with hepatitis C.

Combination therapy with hydrocortisone and fludrocortisone does not improve symptoms in chronic fatigue syndrome: a randomized, placebo-controlled, double-blind, crossover study.

Examining the influence of biological and psychological factors on cognitive performance in chronic fatigue syndrome: a randomized, double-blind, placebo-controlled, crossover study.

Effect of topical nasal corticosteroids on patients with chronic fatigue syndrome and rhinitis.

A pilot randomized controlled trial of dexamphetamine in patients with chronic fatigue syndrome.

Cognitive behavioral therapy and exercise for chronic fatigue syndrome.

Efficacy of distant healing--a proposal for a four-armed randomized study (EUHEALS).

The effect of a polynutrient supplement on fatigue and physical activity of patients with chronic fatigue syndrome: a double-blind randomized controlled trial.

Therapy of circadian rhythm disorders in chronic fatigue syndrome: no symptomatic improvement with melatonin or phototherapy.

Treatment with staphylococcus toxoid in fibromyalgia/chronic fatigue syndrome--a randomised controlled trial.

Neuropsychological performance and noradrenaline function in chronic fatigue syndrome under conditions of high arousal.

Predictors of response to treatment for chronic fatigue syndrome.

Short-term group therapy for patients with chronic fatigue syndrome.

Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial.

Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.

Randomised controlled trial of patient education to encourage graded exercise in chronic fatigue syndrome.

Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial.

Curated Collections

Neuroinflammation Evidence

Metabolism & Mitochondria

Biomarkers

PEM-Specific Research